Registration is now open for our 16th National Conference which will be held in-person in San Francisco, CA from October 28th-30th, 2021, as well as broadcast virtually.
We are thrilled to invite you to this event, which features over 30 nationally recognized anticoagulation experts, who will each be presenting live, in-person!
In order to best support members who may have on-going travel restrictions, we are pleased to offer a virtual attendance option. Sessions will be live streamed with the opportunity to submit questions to presenters in real-time.
Visit our Registration Page to learn more about the Conference experience and whether in-person or virtual attendance is right for you.
Early Registration ends July 1st!
AC Forum Turns 30!
We are so excited to celebrate our 30 years of education and impact and to welcome our new president, Dr. Allison Burnett!!
Watch the video below to hear AC Forum leaders share their stories, experiences, and future goals for our organization!
Missed our 30th Anniversary Virtual Celebration?
Check out the recording here to view the full presentation!
Managing Anticoagulation During the COVID-19 Pandemic
AC Forum will continue to offer guidance on how best to protect your patients and staff while providing anticoagulation management during the current pandemic. Check back often for new updates!
IDEA Committee
In recognizing the impact of systemic racism on health disparities, the Anticoagulation Forum has established the Inclusion, Diversity, Equity, and Allyship (IDEA) Committee. Through the IDEA Committee, the AC Forum will work to increase awareness and promote diversity in our leadership, membership, and programming. We hope our members will engage in this initiative to re-evaluate their current practice, reduce health inequities, and improve the quality of care for all patients.
Learn more here.
News & Announcements:
Combination Aspirin & DOAC Therapy Increases Bleeding Risk
Don’t miss our upcoming webinar on Wednesday, July 21, 2021 @ 12:00 PM ET
From the multi-center MAQI consortium, the authors explored the increased risk of bleeding when patients who were prescribed DOAC medications also were taking aspirin therapy.
Learn more about how the data was collected, how the analyses were conducted, and what steps are being taken to reduce unnecessary aspirin use in order to try and reduce bleeding complications.
Authors:
• Jordan Schaefer, MD
• Geoffrey Barnes, MD, MSc
Moderators:
• Arthur Allen, PharmD, CACP
• Tracy Minichiello, MD
Link to article here.
We are pleased to provide enduring accreditation for this webinar!
Practitioner's Guide for Improving Oral Anticoagulant Use, Online CE from the FDA (CE), June 2020
Free 1-hour course from the FDA on all the fundamental aspects of oral anticoagulation management including overviews of disease state & risk assessment, warfarin, DOACs, DDIs and patient issues such as compliance & joint decision-making; slides and transcript available for download; 1 hour of continuing education credit is available for physicians, nurses & pharmacists until 6/1/23.
View Course Here
FDA-funded Anticoagulation Stewardship Guide
Download our new FDA-funded release, Core Elements of the Anticoagulation Stewardship Program, which outlines systemic protocols designed to improve the safety and quality of care for patients and reduce the adverse drug effects related to anticoagulant medications.
Upcoming Events
-
July 21, 2021 | 12:00 PM ET
Webinar: Combination Aspirin & DOAC Therapy Increases Bleeding Risk
-
October 28th-30th, 2021
AC Forum National Conference
San Francisco, CA
Register by July 1st for Early Bird Rate
Follow Us On Twitter
Sponsored by:
